Bank of America’s Immunome IMNM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.1M Buy
781,607
+578,890
+286% +$12.9M ﹤0.01% 2533
2025
Q4
$4.35M Buy
202,717
+110,562
+120% +$1.94M ﹤0.01% 3496
2025
Q3
$1.08M Sell
92,155
-7,521
-8% -$74.8K ﹤0.01% 5280
2025
Q2
$927K Sell
99,676
-244,715
-71% -$2.01M ﹤0.01% 5345
2025
Q1
$2.32M Buy
344,391
+300,474
+684% +$2.88M ﹤0.01% 4554
2024
Q4
$466K Sell
43,917
-44,020
-50% -$532K ﹤0.01% 5593
2024
Q3
$1.29M Sell
87,937
-151,645
-63% -$2.15M ﹤0.01% 4888
2024
Q2
$2.9M Buy
239,582
+230,215
+2,458% +$3.6M ﹤0.01% 4117
2024
Q1
$231K Sell
9,367
-15,758
-63% -$320K ﹤0.01% 5808
2023
Q4
$269K Buy
25,125
+25,071
+46,428% +$208K ﹤0.01% 5904
2023
Q3
$451 Buy
+54
New +$397 ﹤0.01% 7323
2023
Q1
Sell
-11
Closed -$24 8021
2022
Q4
$24 Buy
+11
New +$44 ﹤0.01% 7945
2022
Q1
Sell
-6,244
Closed -$81K 8488
2021
Q4
$81K Buy
+6,244
New +$111K ﹤0.01% 6984
2021
Q2
Sell
-1,485
Closed -$51K 7884
2021
Q1
$51K Sell
1,485
-1,467
-50% -$36.5K ﹤0.01% 6625
2020
Q4
$28K Buy
+2,952
New +$34.4K ﹤0.01% 6509

Other funds holding IMNM

Bank of America's IMNM Position: Q1 2026 in Review

Bank of America increased its Immunome (IMNM) stake by 286% in Q1 2026, buying an estimated $12.9M and bringing the position to 781,607 shares worth $17.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2533.

Bank of America first reported a position in IMNM in Q4 2020 and has held it in 15 quarters since. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Bank of America held 781,607 shares of Immunome worth $17.1M as of Q1 2026.
  • Bank of America bought 578,890 Immunome shares in Q1 2026, an estimated $12.9M.
  • Immunome made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #2533 holding.
  • Bank of America first reported a position in Immunome in Q4 2020 and has held it in 15 quarters since.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.